3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators

Details for Australian Patent Application No. 2007316180 (hide)

Owner Novartis AG

Inventors Imbach, Patricia; Furet, Pascal

Agent Davies Collison Cave

Pub. Number AU-A-2007316180

PCT Pub. Number WO2008/052964

Priority 06123186.6 30.10.06 EP

Filing date 29 October 2007

Wipo publication date 8 May 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/505 (2006.01) - Pyrimidines

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/052964 Priority application(s): WO2008/052964

13 August 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read 3-aminocarbonyl-substituted fused pyrazoloderivatives as protein kinase modulators

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316189-Process for the biological production of n-butanol with high yield

2007316168-Soluble foaming beverage powder